Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Country/Region as subject
Language
Publication year range
1.
Biochim Biophys Acta Gen Subj ; 1861(1 Pt A): 3388-3398, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27592162

ABSTRACT

BACKGROUND: Equine type 1 polysaccharide storage myopathy (PSSM1) is associated with a missense mutation (R309H) in the glycogen synthase (GYS1) gene, enhanced glycogen synthase (GS) activity and excessive glycogen and amylopectate inclusions in muscle. METHODS: Equine muscle biochemical and recombinant enzyme kinetic assays in vitro and homology modelling in silico, were used to investigate the hypothesis that higher GS activity in affected horse muscle is caused by higher GS expression, dysregulation, or constitutive activation via a conformational change. RESULTS: PSSM1-affected horse muscle had significantly higher glycogen content than control horse muscle despite no difference in GS expression. GS activity was significantly higher in muscle from homozygous mutants than from heterozygote and control horses, in the absence and presence of the allosteric regulator, glucose 6 phosphate (G6P). Muscle from homozygous mutant horses also had significantly increased GS phosphorylation at sites 2+2a and significantly higher AMPKα1 (an upstream kinase) expression than controls, likely reflecting a physiological attempt to reduce GS enzyme activity. Recombinant mutant GS was highly active with a considerably lower Km for UDP-glucose, in the presence and absence of G6P, when compared to wild type GS, and despite its phosphorylation. CONCLUSIONS: Elevated activity of the mutant enzyme is associated with ineffective regulation via phosphorylation rendering it constitutively active. Modelling suggested that the mutation disrupts a salt bridge that normally stabilises the basal state, shifting the equilibrium to the enzyme's active state. GENERAL SIGNIFICANCE: This study explains the gain of function pathogenesis in this highly prevalent polyglucosan myopathy.


Subject(s)
Glycogen Storage Disease/enzymology , Glycogen Storage Disease/epidemiology , Glycogen Synthase/genetics , Horses/metabolism , Mutation/genetics , Adenylate Kinase/metabolism , Amino Acid Sequence , Animals , Blotting, Western , Breeding , Enzyme Activation , Glucose Transporter Type 4/metabolism , Glucose-6-Phosphate/metabolism , Glycogen/metabolism , Glycogen Synthase/chemistry , Glycogen Synthase/metabolism , Glycogen Synthase Kinase 3 beta/metabolism , Kinetics , Models, Molecular , Muscle, Skeletal/enzymology , Mutant Proteins/metabolism , Phosphorylation , Prevalence , Protein Subunits/metabolism , Structural Homology, Protein , Uridine Diphosphate Glucose/metabolism
2.
J Equine Vet Sci ; 136: 105052, 2024 May.
Article in English | MEDLINE | ID: mdl-38531516

ABSTRACT

Quarter horses (QH), a prominent athletic breed in Brazil, are affected by muscular genetic disorders such as myosin-heavy chain myopathy (MYHM), polysaccharide storage myopathy (PSSM1), hyperkalemic periodic paralysis (HyPP), and malignant hyperthermia (MH). Bull-catching (vaquejada), primarily involving QH, is a significant equestrian sport in Brazil. Since the allele frequencies (AF) of MYHM, PSSM1, HyPP, and MH in vaquejada QH remain unknown, this study evaluated the AF in 129 QH vaquejada athletes, specifically from the Brazilian Northeast. These variants were exclusively observed in heterozygosity. The MYHM exhibited the highest AF (0.04 ±0.01), followed by PSSM1 (0.01 ±0.01) and the HyPP variant (0.004 ±0.01), while the MH variant was not identified in this study. This study represents the first identification of these variants in vaquejada QH, emphasizing the need to implement measures to prevent the transmission of pathogenic alleles and reduce the occurrence of clinical cases of these genetic diseases.


Subject(s)
Gene Frequency , Horse Diseases , Horses , Muscular Diseases , Muscular Diseases/congenital , Muscular Diseases/genetics , Muscular Diseases/veterinary , Animals , Horses/genetics , Horse Diseases/genetics , Male , Female , Brazil , Paralysis, Hyperkalemic Periodic/genetics , Paralysis, Hyperkalemic Periodic/veterinary , Malignant Hyperthermia/genetics , Malignant Hyperthermia/veterinary , Polysaccharides/metabolism , Genetic Testing
3.
J Equine Vet Sci ; 116: 104059, 2022 09.
Article in English | MEDLINE | ID: mdl-35777576

ABSTRACT

Genetic disorders are recognised as hereditary diseases with the most significant economic impact on horse breeding, causing important foal losses, costs of treatments of horses, and maintenance of the mare during the pregnancy. The Selle Francais horses are recognized in many countries and are showing great results in equestrian sports around the world (dressage, show jumping and eventing). The study aimed to detect the presence of three mutant alleles associated with inherited diseases including Fragile Foal Syndrome (FFS), Cerebellar Abiotrophy (CA), Polysaccharide Storage Myopathy (PSSM1) and variant impacting gait type in DMRT3. This trait is important for breeding decision in Selle Francais horses and sheds new light on genetic potential and risks on this breed. The genotyping was performed on 91 Selle Francais horses using PCR-RFLP (for POLD1; GYS1 and DMRT3 genes) and PCR-ACRS (TOE1 gene) methods. The presented report indicated the presence of mutant allele A casual for PSSM1 and allele T associated with FFS syndrome occurrence, in 4% and 6% of analysed horses, respectively. Regarding CA, the present survey did not register any cases of this genetic disorder in Selle Francais horses. Our results show also that about 1% of all the Sell Francais horses studied carry the A allele of DMRT3 gene. The present findings have provided data for these fulness of monitoring genetic diseases and gait type in the investigated breed to avoid losses of offspring.


Subject(s)
Cerebellar Diseases , Horse Diseases , Muscular Diseases , Alleles , Animals , Cerebellar Diseases/genetics , Cerebellar Diseases/veterinary , Female , Gait/genetics , Genetic Markers/genetics , Horse Diseases/genetics , Horses/genetics , Muscular Diseases/genetics , Muscular Diseases/veterinary , Phenotype , Polymorphism, Restriction Fragment Length
SELECTION OF CITATIONS
SEARCH DETAIL